Lianbio ADR (LIAN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | LIAN | CLNN | GRCE | ||
| Company | Lianbio ADR | Clene Inc | Grace Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 0.3121 | 3.94 | 3.31 | ||
| High | 0.3498 | 4.29 | 3.44 | ||
| Low | 0.2787 | 3.94 | 3.31 | ||
| Last | 0.3190 | 4.15 | 3.37 | ||
| Change | -0.0288 | +0.27 | +0.02 | ||
| % Change | -8.28% | +6.96% | +0.60% | ||
| Volume | 2,485,000 | 41,000 | 11,100 | ||
| 20-Day Average Volume | 1,788,615 | 82,200 | 27,980 | ||
| Previous Close | 0.3478 | 3.88 | 3.35 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | No | ||
| Technicals | |||||
| 20-Day Moving Average | 4.4191 | 4.97 | 3.18 | ||
| 20-Day Raw Stochastic | 1.01% | 11.32% | 80.33% | ||
| 20-Day Relative Strength | 10.93% | 39.81% | 55.77% | ||
| Weighted Alpha | -25.21 | -59.81 | +32.78 | ||
| Today's Opinion | 8% Buy | 100% Sell | 88% Buy | ||
| Previous Opinion | 16% Buy | 100% Sell | 88% Buy | ||
| Last Month's Opinion | 88% Buy | 16% Sell | 32% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -93.52% since 03/11/24 | +1.47% since 11/20/24 | +2.74% since 11/20/24 | ||
| Low | 0.2712 on 03/15/24 | 3.85 on 11/26/24 | 3.07 on 11/22/24 | ||
| High | 4.9900 on 03/14/24 | 4.59 on 11/25/24 | 3.45 on 11/26/24 | ||
| 1-Month | |||||
| %Chg | -93.31% since 02/16/24 | -22.43% since 10/25/24 | unch since 10/25/24 | ||
| Low | 0.2712 on 03/15/24 | 3.85 on 11/26/24 | 2.88 on 11/06/24 | ||
| High | 4.9900 on 03/14/24 | 6.50 on 11/01/24 | 3.49 on 11/20/24 | ||
| 3-Month | |||||
| %Chg | -92.24% since 12/18/23 | -25.89% since 08/27/24 | +35.89% since 08/27/24 | ||
| Low | 0.2712 on 03/15/24 | 3.85 on 11/26/24 | 2.13 on 09/12/24 | ||
| High | 4.9900 on 03/14/24 | 6.90 on 09/05/24 | 3.60 on 10/23/24 | ||
| 6-Month | |||||
| %Chg | -79.29% since 09/18/23 | -40.88% since 05/24/24 | +23.90% since 05/24/24 | ||
| Low | 0.2712 on 03/15/24 | 3.82 on 08/05/24 | 2.13 on 09/12/24 | ||
| High | 4.9900 on 03/14/24 | 9.20 on 06/07/24 | 3.60 on 10/23/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 34,472 | 34,693 | 34,172 | ||
| Shares Outstanding, K | 108,063 | 8,360 | 10,140 | ||
| Annual Sales | 0 | 650,000 | 0 | ||
| Annual Net Income | -110,290,000 | -49,500,000 | -12,850,000 | ||
| Last Quarter Sales | 0 | 90,000 | 0 | ||
| Last Quarter Net Income | -24,040,000 | -7,990,000 | -3,430,000 | ||
| 60-Month Beta | 0.23 | 0.42 | 1.50 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.22 on 11/13/23 | -1.22 on 11/13/24 | -0.33 on 11/13/24 | ||
| Latest Earnings Date | 03/25/24 | 11/19/24 | 11/11/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||